reference/22133530

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22133530

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	237
issn	1476-5608 1365-7852
issueIdentifier	3
pageRange	228-237
publicationName	Prostate Cancer and Prostatic Diseases
startingPage	228
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b8a5ad79d0fe5c12b38028504d1e14dc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7a24266ab9c1e893634f2e0c753beff1
bibliographicCitation	Furusato B, Tan S, Young D, Dobi A, Sun C, Mohamed AA, Thangapazham R, Chen Y, McMaster G, Sreenath T, Petrovics G, McLeod DG, Srivastava S, Sesterhenn IA. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate Cancer and Prostatic Diseases. 2010 Jun 29;13(3):228–37. doi: 10.1038/pcan.2010.23.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e921dce1c0830a68c4908211f700f804 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94c72980e272720dd2299e509e05e057 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d148c7851f5e31dec86cbcbc5f73f2ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7fa3be0aaa0843adbec3c79c90a75efa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b10bb341243826570a35133dbdc3c9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4c361b2852f76477fea78b0ce2ce3fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b42966ae76defcf84bc41802de2db809 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62a01199915d8043ca473f233f7e3493 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_235ae2d7b386bf84591f6050235a538a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d19b429fccc114e65aa66c7c689573f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2e911e59de7b21fcde731123f7881a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5bf6b7b403fd0331bf7fc32947d67ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46c9c745dae9538db301740b9fc3ad05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1cd4f19054c593277edf1cd58d8c78c
date	2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20585344 https://pubmed.ncbi.nlm.nih.gov/PMC3010744 https://doi.org/10.1038/pcan.2010.23
isPartOf	https://portal.issn.org/resource/ISSN/1476-5608 https://portal.issn.org/resource/ISSN/1365-7852 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30139
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
discusses	http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M0023900 http://id.nlm.nih.gov/mesh/M0195964 http://id.nlm.nih.gov/mesh/M000613727 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M000745465 http://id.nlm.nih.gov/mesh/M0491589 http://id.nlm.nih.gov/mesh/M0406100
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10336 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888769 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364298 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2078

Total number of triples: 60.